Trial
NCT04629209
A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
University of Minnesota
Condition
Glioblastoma
Intervention
ONC201
Why stopped
Change in approach to study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-24